Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. OptiBiotix Health Share Price
  4. OptiBiotix Health Share Regulatory News
  5. Notice of Results

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

OptiBiotix Health Information

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.125
Bid: 17.75
Ask: 18.50
Change: 0.125 (0.69%)
Spread: 0.75 (4.225%)
Open: 18.00
High: 18.125
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

23 Mar 2016 07:00

RNS Number : 9494S
OptiBiotix Health PLC
23 March 2016
 

23 March 2016

OptiBiotix Health Plc

 

Notice of Results

Analyst Briefing

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its preliminary results for the year ended 30 November 2015 on Thursday 14 April 2016.

 

A briefing for analysts will take place in the Gresham room at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW at 9.30am on Thursday 14 April 2016.

 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email optibiotix@walbrookpr.com.

 

 

 For further information:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

Cairn Financial Advisers LLP

Tel: 020 7148 7900

Liam Murray / Avi Robinson

Hybridan LLP (Joint Broker)

Claire Louise Noyce

Tel: 020 3764 2341

Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Mike Wort

Mob: 07900 608 002

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORLLFFRVTIFFIR
12345678910
Date   Source Headline
1st Sep 20172:41 pmRNSExercise of Options and Issue of Equity
30th Aug 20177:00 amRNSHalf-year Report
24th Aug 20177:00 amRNSUS product launch of LPLDL® at trade show
22nd Aug 20177:00 amRNSGlobal manufacturing & supply agreement with Sacco
31st Jul 20174:27 pmRNSTotal Voting Rights
26th Jul 20177:00 amRNSMarket launch for LPLDL® capsules in Germany
17th Jul 20177:00 amRNSSupply agreement with Pharmabiota Ltd
11th Jul 20177:00 amRNSSweetBiotix® development: Results of taste study
6th Jul 20177:00 amRNSGrant of Options
15th Jun 201712:30 pmRNSResult of AGM
15th Jun 20177:00 amRNSSupply agreement with HLH Biopharma GmbH
31st May 20177:00 amRNSHolding(s) in Company
16th May 20177:00 amRNSSuccessful launch of LPLDL and SlimBiome products
9th May 20177:00 amRNSLPLDL® Non-Exclusive European License Agreement
3rd May 20177:00 amRNSPresentation of abstract at conference
25th Apr 20178:50 amRNSFirst German sales
25th Apr 20177:00 amRNSFinal Results
4th Apr 20177:00 amRNSNotice of Results
29th Mar 201710:47 amRNSUK Investor Show attendance
24th Mar 20175:35 pmRNSHolding(s) in Company
21st Mar 201712:00 pmRNSIntention to float SkinBiotherapeutics
15th Mar 20177:00 amRNSConfirmation of Director appointments to the Board
8th Mar 20177:00 amRNSEuropean agreement with Sacco Srl
1st Mar 20177:00 amRNSLaunch of products at Vitafoods 2017
8th Feb 20179:30 amRNSExercise of Warrants and Issue of Equity
26th Jan 20172:06 pmRNSResult of General Meeting
24th Jan 20177:00 amRNSPresentation of research data
18th Jan 20177:00 amRNSAppointment of Sales and Marketing Director
17th Jan 20174:50 pmRNSHolding(s) in Company
13th Jan 20173:44 pmRNSExercise of Option and Issue of Equity
12th Jan 20177:00 amRNSPresentation of research data at ProBiota 2017
11th Jan 201710:04 amRNSExercise of Warrants and Issue of Equity
5th Jan 20177:00 amRNSAppointment of Commercial Director
3rd Jan 20177:00 amRNSIncreased investment in THWLC
23rd Dec 20167:00 amRNSNotice of General Meeting of Warrant Holders
13th Dec 20167:00 amRNSJoint Product Agreement with multinational
1st Dec 20167:00 amRNSExercise of Warrants and Issue of Equity
29th Nov 20167:00 amRNSScientific and Commercial Update
3rd Nov 20167:00 amRNSPresentation of data at European Microbiome Summit
26th Oct 20167:00 amRNSScientific and commerical update
20th Oct 20167:00 amRNSIncreased investment in SkinBiotix Ltd
5th Oct 20167:00 amRNSAppointment of a Chairman for SkinBiotix
28th Sep 20167:00 amRNSChange of Adviser
23rd Sep 20168:29 amRNSExercise of Warrants and Issue of Equity
14th Sep 20164:38 pmRNSHolding(s) in Company
6th Sep 20167:00 amRNSConsumer survey results of GoFigure products
25th Aug 20167:00 amRNSHalf-year Report
12th Aug 20163:11 pmRNSExercise of Warrants and Issue of Equity
9th Aug 20167:00 amRNSFirst products in Whole Foods Market Inc
3rd Aug 20167:00 amRNSNotice of Results
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.